General Updates

July 11, 2026 To, To, Listing Department, The National Stock Exchange of India BSE Limited Ltd. Phiroze Jeejeebhoy Towers, The Listing Department Dalal Street, Exchange Plaza, Mumbai – 400 001 Bandra – Kurla Complex, Ref: BSE Scrip Code: 544497 Mumbai – 400051, NSE Scrip Code: AHCL Sub: Intimation under Regulation 30 of Securities and Exchange Board of India ("SEBI”) (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations") – Incorporation of Subsidiary. Respected Sir/Madam, With reference to our earlier intimation dated Wednesday, July 01, 2026 with respect to proposal to incorporate subsidiary of Anlon Healthcare Limited (“Company”), we wish to inform you that pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations") read with SEBI Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated January 30, 2026 (“SEBI Master Circular”), “ANLON BIOLOGICS PRIVATE LIMITED” having corporate identification number “U21000GJ2026PTC180405” has been incorporated as a subsidiary of the Company, with effect from July 10, 2026. The relevant details pursuant to Schedule III of the Listing Regulations and additional details as required under the SEBI Master Circular for compliance with the provisions of the Listing Regulations by listed entities is annexed in Annexure – A. You are requested to take the above information on your record. Thanking You. For ANLON HEALTHCARE LIMITED PUNITKUMAR RASADIA MANAGING DIRECTOR DIN: 06696258 ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in ANNEXURE-A Details required under Regulation 30 of SEBI LODR read with HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026 Sr Particulars Description 1 Name of the target entity, country of Name of the Entity: ANLON incorporation, details in brief such as size, BIOLOGICS PRIVATE LIMITED. turnover etc. Country of Incorporation: India Turnover: Nil as the company is the newly incorporated company Size of the Company: Company is incorporated with authorized share capital of Rs. 1,000,000/- and paid up share capital of Rs. 1,000,000/-. 2 Whether the incorporation of subsidiary Not applicable would fall within related party transaction(s) and whether the promoter/ promoter group/ group companies have any interest in the entity being acquired? If yes, nature of interest and details thereof and whether the same is done at “arm’s length” 3 Industry to which the entity being Pharmaceuticals incorporated belongs 4 Objects and impact of acquisition The purpose of acquisition/ (including but not limited to, disclosure of incorporation of this subsidiary is reasons for acquisition of target entity, if aligned with the Company’s long- its business is outside the main line of term growth objective. Considering business of the listed entity) this subsidiary would be manufacturing surgical implants and medical devices, the Company intends to leverage this opportunity in order to strategically complement and expand its existing business in the pain management segment. 5 Brief details of any governmental or Not applicable regulatory approvals required for the incorporation/ acquisition 6 Indicative time period for completion of Incorporated on July 10, 2026 the acquisition 7 Consideration - whether cash Subscription to the share capital of consideration or share swap or any other the subsidiary is by way of cash / form and details of the same banking channel. 8 Cost of subscription / price at which the Equity shares subscribed by Anlon shares are subscribed Healthcare Limited at an aggregate of Rs. 650,000/- (Rupees Six Lakhs Fifty Thousand Only) to subscribe 65,000/- (Sixty Five Thousand) equity shares of face value Rs. 10 /- ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in each (Rupees Ten only) of the subsidiary company. 9 Percentage of shareholding/ control by 65% of the share capital of ANLON the listed entity and / or number of shares BIOLOGICS PRIVATE LIMITED is allotted held by Anlon Healthcare Limited i.e. 65,000/- (Sixty Five Thousand) equity shares of face value Rs. 10 /- each (Rupees Ten only) of the subsidiary company. 10 Brief background about the entity This Company is being established acquired/ incorporated in terms of for the development and products/line of business acquired, date manufacture of peptides, of incorporation, history of last 3 years biosimilars, biological compositions turnover, country in which the acquired and allied products. In view of the entity has presence and any other anticipated growth of this sector in significant information (in brief) the coming years, the Company seeks to strategically position itself to benefit from the expanding opportunities in this segment. Date of Incorporation: 10/07/2026 Turnover: Not applicable (It is a newly incorporated Company and is yet to commence its business) Country in which the incorporated entity has presence: India. ANLON HEALTHCARE LIMITED CIN No.: U24230GJ2013PLC077543 REGISTERED OFFICE: 101/102, Silver Coin Complex, Opp. Crystal Mall, Kalawad Road, Rajkot- 360005, Gujarat (INDIA) PHONE NO.: +91-7069690081/82 | Email: info@anlonhealthcare.com | www.anlon.in